Skip to main content
TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · IEX Real-Time Price · USD
9.31
0.00 (0.00%)
May 1, 2024, 4:30 PM EDT - Market closed

TriSalus Life Sciences Market Cap

TriSalus Life Sciences has a market cap or net worth of $280.22 million as of May 1, 2024. Its market cap has increased by 230.83% in one year.

Market Cap
280.22M
Enterprise Value
270.03M
1-Year Change
230.83%
Ranking
#3379
Category
Micro-Cap
Stock Price
$9.31

Market Cap Chart

Since December 18, 2020, TriSalus Life Sciences's market cap has increased from $259.00M to $280.22M, an increase of 8.19%. That is a compound annual growth rate of 2.37%.

History

DateMarket Cap% Change
Apr 30, 2024249.10M-0.60%
Apr 29, 2024250.60M0.16%
Apr 26, 2024250.20M-5.83%
Apr 25, 2024265.70M-3.03%
Apr 24, 2024274.00M0.40%
Apr 23, 2024272.90M3.65%
Apr 22, 2024263.30M3.70%
Apr 19, 2024253.90M-3.46%
Apr 18, 2024263.00M1.11%
Apr 17, 2024260.10M1.05%
Apr 16, 2024257.40M1.26%
Apr 15, 2024254.20M0.75%
Apr 12, 2024252.30M-3.11%
Apr 11, 2024260.40M2.00%
Apr 10, 2024255.30M-1.01%
Apr 9, 2024257.90M-3.55%
Apr 8, 2024267.40M3.68%
Apr 5, 2024257.90M-
Apr 4, 2024257.90M0.19%
Apr 3, 2024257.40M-0.19%
Apr 2, 2024257.90M-4.38%
Apr 1, 2024269.70M5.11%
Mar 28, 2024256.60M3.30%
Mar 27, 2024248.40M1.26%
Mar 26, 2024245.30M-
View and export this data all the way back to 2020. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Enanta Pharmaceuticals 290.68M
Black Diamond Therapeutics 288.07M
CorMedix 288.04M
ESSA Pharma 284.45M
Acrivon Therapeutics 280.63M
AxoGen 280.15M
Opthea 276.72M
Nanobiotix 275.13M
Market Cap Rankings